entertainment -WSS

entertainment

author：fashion 2025-10-01 17:35:10 - browse：7849

An ALS patient receives support. -- health coverage from STAT — Adobe

Years of polarizing scientific discourse and bruising online debate will come to a head next week when advisers to the Food and Drug Administration weigh in on NurOwn, a potential treatment to slow the progression of ALS that has bitterly divided physicians and patient advocates.

On Sept. 27, a panel of experts will consider the convoluted data supporting the potential approval of NurOwn, a stem-cell therapy the FDA previously refused to even consider. To some physicians, the drug’s failure to show significant benefits in clinical studies leaves approval out of the question. Others, including the influential ALS Association, say NurOwn’s manufacturer, a small biotech firm called BrainStorm Cell Therapeutics, hasn’t disclosed enough information to properly determine the medicine’s value.

Another group of patients and doctors argue that NurOwn’s supporting evidence, while problematic, justifies making it available to the roughly 30,000 ALS patients in the U.S., people for whom there is currently no hope of arresting an incurable disease that gradually erodes motor function and leads to death within about five years of diagnosis.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Why is France rioting? What to know about the fatal police shooting of Nahel M

hotspot

entertainment

WSS

Why is France rioting? What to know about the fatal police shooting of Nahel M

Liz Cheney makes 1st public comment since Trump's election interference indictments

Can food be medicine? And other questions about a new push

Lung cancer is America's deadliest cancer. Yet so few get screened

Living with Hashimoto's and celiac disease, and med school, too

Hilary may become 1st tropical storm to make landfall in California in 84 years

explore

entertainment

hotspot

Malaria cases in Florida and Texas: Here’s what you need to know

Bacterial infection may be ‘key event’ in endometriosis, study says

Virginia high school admissions case could be legal follow

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

How one medical school became remarkably diverse

Cancer drug shortages' outsize impact on ovarian cancer patients

Dobbs anniversary: the lost opportunity of abortion as health care

Patient advocates sound warning on FDA proposal on salt intake

Jerome Adams on the need for new antivirals for Covid

Connecting traumatic brain injury and domestic violence

hotspot

Why is France rioting? What to know about the fatal police shooting of Nahel M

New definition of a human embryo proposed amid rapid advances

Listen: Racing for gene therapy & a pioneering approval

Doctor appointment wait times are getting worse

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

Brain 'hot spot' may explain why African Americans feel greater pain

knowledge

hotspot

entertainment

hotspot